Equities

Microwave Chemical Co Ltd

9227:TYO

Microwave Chemical Co Ltd

Actions
IndustrialsIndustrial Engineering
  • Price (JPY)1,095.00
  • Today's Change35.00 / 3.30%
  • Shares traded603.20k
  • 1 Year change-33.11%
  • Beta--
Data delayed at least 20 minutes, as of May 10 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Microwave Chemical Co Ltd is a Japan-based company mainly engaged in the microwave chemistry-related businesses. The Company is engaged in the research, development and engineering of microwave chemistry processes. The Company is engaged in the provision of one-stop solutions from research and development to engineering and manufacturing support according to customer issues. The research, development and engineering solutions have four phases: lab development, demonstration development, actual machine introduction (equipment sales), and manufacturing support. The Company is also engaged in the manufacture and sale of products that utilize microwave chemistry processes.

  • Revenue in JPY (TTM)1.89bn
  • Net income in JPY98.88m
  • Incorporated2007
  • Employees59.00
  • Location
    Microwave Chemical Co Ltd5F, Photonics Center, 2-1, YamadaokaSUITA-SHI 565-0871JapanJPN
  • Phone+81 661707595
  • Fax+81 661707596
  • Websitehttps://mwcc.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Linical Co Ltd12.52bn680.40m10.24bn759.0013.741.208.610.818130.1230.12554.28346.380.7251--3.9916,494,230.003.944.716.557.2333.1031.605.435.98--17,809.030.279345.368.326.5527.06-4.97-33.014.94
AnGes Inc152.99m-7.44bn10.67bn145.00--0.3726--69.72-39.40-39.400.8083131.520.00450.10378.401,055,069.00-21.97-28.50-25.69-33.1412.7139.42-4,861.66-6,726.821.75--0.0137--128.13-24.1749.45--12.11--
KOEI CHEMICAL COMPANY, LIMITED18.49bn62.58m11.10bn387.00177.030.51043.770.600312.7912.793,779.784,437.990.45991.304.5147,770,930.000.15573.760.2064.6824.9124.120.33856.660.53561.770.308935.807.550.4997-26.56-33.8215.6820.11
Medinet Co Ltd724.63m-1.41bn11.54bn98.00--1.97--15.93-6.31-6.313.2322.880.122411.933.617,394,143.00-23.74-21.05-24.75-22.4717.7228.75-193.90-135.4019.58--0.00--4.40-7.90-14.66---17.67--
ReproCell Inc2.51bn-217.49m11.99bn92.00--1.47--4.78-2.56-2.5629.4890.900.30084.867.4427,247,390.00-2.61-9.37-2.80-10.1143.5538.78-8.68-38.1211.94--0.00--32.1626.1046.91--28.24--
Nano Mrna Co Ltd164.39m-1.05bn12.53bn17.00--3.60--76.22-14.94-14.942.3449.400.029518.962.609,669,765.00-18.85-25.13-23.29-26.0480.6784.69-638.22-538.318.95--0.2418---23.42-4.8430.33------
RaQualia Pharma Inc1.90bn-323.66m12.94bn67.00--2.11--6.81-14.99-14.9987.98283.050.28963.133.1528,376,150.00-4.932.13-5.292.2687.1188.49-17.025.3212.35--0.05670.00-34.8520.62-144.74--0.0967--
Healios KK121.00m-3.82bn13.97bn64.00--3.00--115.46-55.07-55.071.7851.710.008--0.39291,890,625.00-25.27-23.55-35.99-28.5283.47---3,152.89-6,580.16---13.680.6756--34.44--26.04---22.00--
Oncolys Biopharma Inc63.04m-1.94bn14.40bn34.00--9.15--228.44-108.23-108.233.5475.100.02692.190.30011,854,059.00-82.64-45.75-97.13-51.8648.5560.46-3,075.14-233.665.15--0.1761---93.54-17.86-68.72--28.18--
Ohki Healthcare Holdings Co Ltd327.51bn2.35bn14.49bn576.006.050.5385.460.0443170.32170.3223,747.191,914.312.3711.644.27568,593,700.001.651.957.989.115.207.120.69620.75390.8536--0.1913.289.454.91124.49-1.16-1.279.46
Microwave Chemical Co Ltd1.89bn98.88m17.11bn59.00246.0210.0297.169.044.454.45116.78109.320.65269.376.5332,055,120.003.41--4.65--54.51--5.23--2.6511.240.2309--41.24--168.39------
TAIKO PHARMACEUTICAL CO LTD6.12bn-3.61bn18.03bn208.00--2.64--2.95-73.48-73.48129.22134.920.4332.133.2429,423,080.00-25.54---32.19--42.11---58.99--2.54--0.3256--21.43--26.23------
Astena Holdings Co Ltd52.63bn1.62bn20.41bn1.40k12.150.68935.310.387840.9840.981,332.61722.460.81273.312.7637,482,540.002.492.494.444.4432.2725.333.062.320.8713--0.351744.924.73-2.85100.61-3.8538.5411.38
Fuso Pharmaceutical Industries Ltd54.63bn1.34bn21.22bn1.31k14.490.52666.020.3884154.89154.896,295.264,263.410.7253.312.2041,572,300.001.781.792.952.8725.2927.782.452.591.0965.130.283545.952.792.148.2310.60-1.72-2.64
Medical Data Vision Co Ltd6.42bn979.13m22.10bn262.0021.544.9620.923.4425.6325.63168.05111.301.15140.016.1124,500,100.0017.1716.1624.0120.8878.3881.9014.8715.522.5824.660.0019.985.1512.4012.4869.75-23.95--
Data as of May 10 2024. Currency figures normalised to Microwave Chemical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.67%Per cent of shares held by top holders
HolderShares% Held
Simplex Asset Management Co., Ltd.as of 04 Apr 202459.40k0.38%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 12 Sep 202244.00k0.28%
TORANOTEC Asset Management Co., Ltd.as of 20 Jul 20221.00k0.01%
Daiwa Asset Management Co. Ltd.as of 31 Dec 2023100.000.00%
SBI Okasan Asset Management Co. Ltd.as of 15 Jun 20230.000.00%
More ▼
Data from 20 Jul 2022 - 01 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.